GW-501516

GW-501516 Product Description — Research Use Only

GW-501516 is a research compound studied as a selective PPARδ receptor agonist. It is not a peptide, but it is often grouped within peptide and research-compound catalogs. PPARδ pathways are commonly connected to fatty-acid metabolism, energy use, skeletal-muscle signaling, endurance-related research, lipid regulation, and metabolic-response studies.

Research on GW-501516 has most commonly focused on fatty-acid oxidation, endurance pathways, skeletal-muscle metabolism, lipid processing, energy balance, AMPK-related signaling, and PPARδ receptor activity. Published studies describe GW-501516 as a PPARδ agonist used to study how metabolic tissues shift fuel use and regulate genes involved in fat oxidation and energy production.

GW-501516 is commonly studied for:

• PPARδ activity — how the compound activates PPARδ receptor pathways

• Fat metabolism — how cells process and use fatty acids for energy

• Endurance research — pathways connected to stamina, output, and energy efficiency

• Skeletal-muscle signaling — how muscle cells regulate fuel use and oxidative activity

• Energy balance — how cells manage fuel storage, fuel use, and metabolic demand

• Lipid processing — how fats are broken down, transported, and used

• Metabolic research — pathways connected to glucose, fat, and overall energy regulation

GW-501516 is commonly studied because PPARδ activation is linked to changes in fuel selection and oxidative metabolism. Research has reported increased fatty-acid oxidation pathways in skeletal muscle and liver-related metabolic models, along with effects on PGC-1α, AMPK-related signaling, and genes involved in lipid use.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.